Top Stem Cell Researcher Shines Light on High Potency Treatments at Davos
World-renowned stem cell researcher and orthopedic surgeon set to introduce studies on high potency stem cell treatments at the World Economic Forum
NEW YORK - Jan. 17, 2014 - PRLog -- World-renowned stem cell researcher and founder of Blue Horizon International (BHI), Brian Mehling, MD, will present his studies during The World Economic Forum Annual Meeting on Jan. 22 in Davos-Klosters, Switzerland. During his visit, Dr. Mehling and a few BHI patients will be available for interviews about treatments they have personally undergone.
“Stem cell treatments are without a doubt the future of medicine,” Dr. Mehling stated. “It is very important that people making decisions on what direction the world will take in regards to research and medical treatments are educated about not only the possibilities in stem cell research, but also about all the treatments that are already available for many patients with different chronic conditions.”
The event will explore ideas, innovations and discoveries in art, culture, engineering, media, medicine, science and technology that have reshaped our planet.
BHI is a health care consulting company with a unique mission that combines providing quality care to patients, cutting-edge stem cell therapies to emerging markets, and philanthropy to the underserved. Its subsidiaries have safely and efficiently performed and documented over 2,600 stem cell therapy procedures on over 600 patients worldwide. For more information, visit www.bluehorizonstemcells.com.
Bookings can be arranged through the BHSC media offices.
Blue Horizon International
Page Updated Last on: Jan 18, 2014